EVP & Vice Chairman · Royalty Pharma plc · Class A Ordinary Shares
Side
A
Value
—
Shares
26.6K
Price
—
Executed
Feb 11, 2026
Disclosed
Feb 13, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 11 executedFeb 13, 2026 disclosed
RPRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · 4.0% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hite Christopher filed this Form 4 reporting a grant or award of RPRX on Feb 11, 2026. It became public on Feb 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP & Vice Chairman
Hite Christophercik:0001814238
Issuer
Royalty Pharma plccik:0001802768
Revision history · 0
No field has changed since this record was first ingested.
